GSK vs. ^GSPC
Compare and contrast key facts about GlaxoSmithKline plc (GSK) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK or ^GSPC.
Performance
GSK vs. ^GSPC - Performance Comparison
Returns By Period
In the year-to-date period, GSK achieves a -6.46% return, which is significantly lower than ^GSPC's 23.62% return. Over the past 10 years, GSK has underperformed ^GSPC with an annualized return of 1.53%, while ^GSPC has yielded a comparatively higher 11.16% annualized return.
GSK
-6.46%
-12.50%
-24.30%
-1.51%
-1.61%
1.53%
^GSPC
23.62%
0.54%
11.19%
30.63%
13.61%
11.16%
Key characteristics
| GSK | ^GSPC | |
|---|---|---|
| Sharpe Ratio | 0.07 | 2.51 |
| Sortino Ratio | 0.25 | 3.37 |
| Omega Ratio | 1.03 | 1.47 |
| Calmar Ratio | 0.06 | 3.63 |
| Martin Ratio | 0.17 | 16.15 |
| Ulcer Index | 9.29% | 1.91% |
| Daily Std Dev | 21.65% | 12.27% |
| Max Drawdown | -55.21% | -56.78% |
| Current Drawdown | -25.62% | -1.75% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between GSK and ^GSPC is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Risk-Adjusted Performance
GSK vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Drawdowns
GSK vs. ^GSPC - Drawdown Comparison
The maximum GSK drawdown since its inception was -55.21%, roughly equal to the maximum ^GSPC drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for GSK and ^GSPC. For additional features, visit the drawdowns tool.
Volatility
GSK vs. ^GSPC - Volatility Comparison
GlaxoSmithKline plc (GSK) has a higher volatility of 6.04% compared to S&P 500 (^GSPC) at 4.07%. This indicates that GSK's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.